FGL1 (human) Matched Pair Detection Set (mAb-based)-抗体对-深圳欣博盛生物科技有限公司

首页产品中心抗体对

FGL1 (human) Matched Pair Detection Set (mAb-based)

品牌：Adipogen

官网链接

说明书

折扣/货期

货号：AG-46B-0014-KI01

规格：1 Set

目录价：￥7800

产品详情

* 以下信息仅供参考，详情请以原厂网站为准

产品名称:

FGL1 (human) Matched Pair Detection Set (mAb-based)

别名:

Fibrinogen-like Protein 1; FGL-1; Hepatocyte-derived Fibrinogen-related Protein 1; HFREP-1; Hepassocin

产品描述:

FGL1 (Fibrinogen-like protein 1, also called Hepatocyte-derived fibrinogen-related protein 1, HFREP-1 or Hepassocin) was initially identified as an overexpressed transcript in hepatocyte carcinoma and as a transcript enriched in regenerating liver. FGL1 is expressed at lower levels in brown and white adipose in the setting of liver injury. A low level expression of FGL1 is also observed in the pancreas. FGL1 is a 34kDa protein structurally similar to Angiopoietin-like factors 2, 3, 4 and 6, which regulate lipid metabolism and energy utilization. It was proposed that FGL1 is a member of an emerging group of proteins having potential roles in liver metabolism and liver regeneration. Recently, FGL1 has also been shown to be upregulated in human cancers and FGL1 is a major functional ligand of LAG-3. FGL1 interacts with LAG-3 in a MHC-II-independent manner and this interaction involves the FGL1 fibrinogen-like domain and the LAG-3 D1-D2 domain. FGL1-LAG-3 interaction blockade promotes tumor immunity by stimulating T cell expansion and activation. FGL1 forms two disulfide-linked homodimers and also higher molecular weight homooligomers that bind to LAG-3 much better than the dimeric forms. This binding to LAG-3 inhibits T cell responses. FGL1 is highly produced by human cancer cells, and elevated FGL1 in the plasma of cancer patients is associated with a poor prognosis and resistance to anti-PD-1/ B7-H1 therapy.

靶标/特异性:

Detects human FGL1 in serum, plasma and cell culture supernatant.

保存温度:

+4°C

运输温度:

产地:

瑞士

灵敏度:

<5 pg/ml

检测范围:

7.8 pg/ml to 500 pg/ml

检测方法: